Survival differences in pulmonary metastatic osteosarcoma between pediatric and adult institutions

Daniel R Liesman1, William J Kacey1, Kelly R Bates1

  • 1Department of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital, Northwestern University, Chicago, IL, USA.

PubMed

Insights

Patients with relapsed osteosarcoma and lung metastases treated at pediatric hospitals showed improved survival. Further studies are needed to identify specific treatment factors influencing outcomes in osteosarcoma patients.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Osteosarcoma with pulmonary metastases has a poor prognosis.
  • Pediatric surgeons may use more aggressive treatments than adult surgeons for metastatic osteosarcoma.
  • The impact of institutional care setting on survival for relapsed osteosarcoma is unclear.

Purpose of the Study:

  • To test the hypothesis that pediatric patients with relapsed pulmonary metastatic osteosarcoma treated at pediatric institutions have improved survival compared to those treated at adult institutions.
  • To explore differences in treatment approaches between pediatric and adult institutions for relapsed osteosarcoma.

Main Methods:

  • Retrospective chart review of adult and pediatric patients with relapsed pulmonary osteosarcoma.
  • Exclusion of adult patients over 60 to minimize comorbidity effects.
  • Survival analysis using Kaplan-Meier estimates and Cox regression models.

Main Results:

  • 28 pediatric and 24 adult patients were included.
  • Pediatric patients more frequently had extremity tumors (82% vs. 46%).
  • Care at a pediatric institution was associated with improved overall survival on univariable analysis (HR 0.48; P=0.028), but not independently predictive on multivariable analysis.

Conclusions:

  • Patients treated at pediatric institutions demonstrated improved survival after pulmonary relapse of osteosarcoma.
  • While institutional care alone was not independently predictive, findings support further multi-institutional research.
  • Identifying modifiable factors influencing outcomes in relapsed osteosarcoma is crucial.
Abstract